Structure

Physi-Chem Properties

Molecular Weight:  300.06
Volume:  291.273
LogP:  3.616
LogD:  2.963
LogS:  -4.001
# Rotatable Bonds:  3
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.643
Synthetic Accessibility Score:  2.724
Fsp3:  0.062
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.985
MDCK Permeability:  8.542131581634749e-06
Pgp-inhibitor:  0.003
Pgp-substrate:  0.272
Human Intestinal Absorption (HIA):  0.018
20% Bioavailability (F20%):  0.688
30% Bioavailability (F30%):  0.99

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.007
Plasma Protein Binding (PPB):  97.82869720458984%
Volume Distribution (VD):  0.618
Pgp-substrate:  3.751495361328125%

ADMET: Metabolism

CYP1A2-inhibitor:  0.977
CYP1A2-substrate:  0.611
CYP2C19-inhibitor:  0.29
CYP2C19-substrate:  0.056
CYP2C9-inhibitor:  0.646
CYP2C9-substrate:  0.937
CYP2D6-inhibitor:  0.731
CYP2D6-substrate:  0.793
CYP3A4-inhibitor:  0.722
CYP3A4-substrate:  0.099

ADMET: Excretion

Clearance (CL):  9.185
Half-life (T1/2):  0.793

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.099
Drug-inuced Liver Injury (DILI):  0.955
AMES Toxicity:  0.652
Rat Oral Acute Toxicity:  0.02
Maximum Recommended Daily Dose:  0.856
Skin Sensitization:  0.161
Carcinogencity:  0.048
Eye Corrosion:  0.101
Eye Irritation:  0.945
Respiratory Toxicity:  0.366

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC67654

Natural Product ID:  NPC67654
Common Name*:   Ebenfuran Ii
IUPAC Name:   2-(2,4-dihydroxyphenyl)-4-hydroxy-6-methoxy-1-benzofuran-3-carbaldehyde
Synonyms:   Ebenfuran II
Standard InCHIKey:  MYAHOBWCBIQQLV-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H12O6/c1-21-9-5-13(20)15-11(7-17)16(22-14(15)6-9)10-3-2-8(18)4-12(10)19/h2-7,18-20H,1H3
SMILES:  COc1cc(O)c2c(c1)oc(c2C=O)c1ccc(cc1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL491705
PubChem CID:   10266789
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[11141112]
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[18986200]
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT108 Individual Protein Estrogen receptor alpha Homo sapiens RBA = 0.28 n.a. PMID[544903]
NPT108 Individual Protein Estrogen receptor alpha Homo sapiens IC50 = 43.0 nM PMID[544903]
NPT83 Cell Line MCF7 Homo sapiens Activity = 111.0 % PMID[544904]
NPT83 Cell Line MCF7 Homo sapiens EC50 = 5500.0 nM PMID[544904]
NPT83 Cell Line MCF7 Homo sapiens Activity = 64.0 % PMID[544904]
NPT108 Individual Protein Estrogen receptor alpha Homo sapiens RBA = 0.18 n.a. PMID[544904]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC67654 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9931 High Similarity NPC156244
0.9797 High Similarity NPC160015
0.9797 High Similarity NPC247677
0.9732 High Similarity NPC260902
0.9732 High Similarity NPC296957
0.9667 High Similarity NPC476350
0.9667 High Similarity NPC476349
0.9517 High Similarity NPC230943
0.9463 High Similarity NPC263676
0.9448 High Similarity NPC302181
0.9408 High Similarity NPC472877
0.94 High Similarity NPC1477
0.94 High Similarity NPC213608
0.9396 High Similarity NPC116604
0.9396 High Similarity NPC115324
0.9392 High Similarity NPC226644
0.9392 High Similarity NPC37226
0.9388 High Similarity NPC17816
0.9379 High Similarity NPC53192
0.9333 High Similarity NPC207624
0.9333 High Similarity NPC5871
0.9324 High Similarity NPC135325
0.9272 High Similarity NPC122365
0.9267 High Similarity NPC106372
0.9267 High Similarity NPC58668
0.9267 High Similarity NPC170169
0.9267 High Similarity NPC23668
0.9267 High Similarity NPC193976
0.9262 High Similarity NPC39929
0.9262 High Similarity NPC296030
0.9257 High Similarity NPC12148
0.9257 High Similarity NPC130581
0.9252 High Similarity NPC98926
0.9252 High Similarity NPC155144
0.9231 High Similarity NPC291110
0.9221 High Similarity NPC260296
0.9221 High Similarity NPC115432
0.9216 High Similarity NPC65504
0.9211 High Similarity NPC198490
0.9211 High Similarity NPC148938
0.9205 High Similarity NPC41326
0.9205 High Similarity NPC253872
0.9205 High Similarity NPC142308
0.92 High Similarity NPC167576
0.92 High Similarity NPC78335
0.92 High Similarity NPC230713
0.9189 High Similarity NPC51641
0.9189 High Similarity NPC300267
0.9189 High Similarity NPC210826
0.9184 High Similarity NPC225884
0.9161 High Similarity NPC304387
0.9156 High Similarity NPC244750
0.9156 High Similarity NPC40583
0.9145 High Similarity NPC158261
0.9145 High Similarity NPC235333
0.9145 High Similarity NPC183874
0.9145 High Similarity NPC42458
0.9133 High Similarity NPC178202
0.9128 High Similarity NPC198427
0.9122 High Similarity NPC303185
0.9122 High Similarity NPC184649
0.9108 High Similarity NPC136641
0.9103 High Similarity NPC193998
0.9091 High Similarity NPC212967
0.9091 High Similarity NPC246647
0.9091 High Similarity NPC96342
0.9091 High Similarity NPC164110
0.9091 High Similarity NPC270044
0.9085 High Similarity NPC99199
0.9085 High Similarity NPC297531
0.9085 High Similarity NPC213936
0.9085 High Similarity NPC474542
0.9073 High Similarity NPC135303
0.9073 High Similarity NPC472406
0.9073 High Similarity NPC148423
0.906 High Similarity NPC299011
0.9054 High Similarity NPC113770
0.9045 High Similarity NPC155640
0.9045 High Similarity NPC38591
0.9026 High Similarity NPC180924
0.9026 High Similarity NPC13879
0.902 High Similarity NPC472462
0.902 High Similarity NPC72370
0.9007 High Similarity NPC221868
0.9007 High Similarity NPC317492
0.9007 High Similarity NPC37208
0.8994 High Similarity NPC320789
0.8993 High Similarity NPC311144
0.8986 High Similarity NPC202981
0.8973 High Similarity NPC124269
0.8968 High Similarity NPC269495
0.8968 High Similarity NPC268360
0.8954 High Similarity NPC38361
0.8954 High Similarity NPC130015
0.8951 High Similarity NPC290304
0.8951 High Similarity NPC236327
0.8947 High Similarity NPC155882
0.894 High Similarity NPC272194
0.894 High Similarity NPC168085
0.894 High Similarity NPC39195
0.894 High Similarity NPC306788
0.8933 High Similarity NPC190572
0.8924 High Similarity NPC109180
0.8917 High Similarity NPC188486
0.8904 High Similarity NPC188879
0.8903 High Similarity NPC137100
0.8903 High Similarity NPC45131
0.8896 High Similarity NPC41719
0.8889 High Similarity NPC472407
0.8882 High Similarity NPC120220
0.8882 High Similarity NPC131866
0.8882 High Similarity NPC88445
0.8874 High Similarity NPC308200
0.8868 High Similarity NPC38914
0.8861 High Similarity NPC219861
0.8861 High Similarity NPC84515
0.8861 High Similarity NPC312056
0.8859 High Similarity NPC96791
0.8859 High Similarity NPC470636
0.8859 High Similarity NPC226942
0.8854 High Similarity NPC304839
0.8854 High Similarity NPC220582
0.8854 High Similarity NPC169
0.8844 High Similarity NPC188947
0.8844 High Similarity NPC55162
0.8844 High Similarity NPC278323
0.8844 High Similarity NPC12175
0.8844 High Similarity NPC280284
0.8844 High Similarity NPC309154
0.8844 High Similarity NPC90665
0.8844 High Similarity NPC279668
0.8844 High Similarity NPC99333
0.8839 High Similarity NPC233776
0.8836 High Similarity NPC240593
0.8827 High Similarity NPC472584
0.8824 High Similarity NPC476185
0.8824 High Similarity NPC267117
0.8824 High Similarity NPC472421
0.8824 High Similarity NPC321896
0.8824 High Similarity NPC191104
0.882 High Similarity NPC53252
0.8816 High Similarity NPC145467
0.8812 High Similarity NPC277480
0.8812 High Similarity NPC53640
0.8808 High Similarity NPC73320
0.8805 High Similarity NPC472581
0.8797 High Similarity NPC74854
0.8797 High Similarity NPC30655
0.8797 High Similarity NPC45124
0.8792 High Similarity NPC3188
0.879 High Similarity NPC16935
0.879 High Similarity NPC196879
0.8784 High Similarity NPC150648
0.8784 High Similarity NPC316480
0.8784 High Similarity NPC274784
0.8784 High Similarity NPC329203
0.8784 High Similarity NPC137009
0.8784 High Similarity NPC265871
0.8784 High Similarity NPC222342
0.8784 High Similarity NPC225153
0.8784 High Similarity NPC20709
0.8784 High Similarity NPC310135
0.8784 High Similarity NPC261234
0.8782 High Similarity NPC474386
0.8776 High Similarity NPC303644
0.8776 High Similarity NPC275055
0.8776 High Similarity NPC162680
0.8776 High Similarity NPC290291
0.8776 High Similarity NPC228661
0.8776 High Similarity NPC209560
0.8776 High Similarity NPC294409
0.8776 High Similarity NPC250266
0.8776 High Similarity NPC266597
0.8776 High Similarity NPC181124
0.8776 High Similarity NPC116632
0.8776 High Similarity NPC7013
0.8766 High Similarity NPC474772
0.8766 High Similarity NPC472423
0.8766 High Similarity NPC318424
0.8766 High Similarity NPC474744
0.8766 High Similarity NPC471229
0.8758 High Similarity NPC277032
0.8758 High Similarity NPC247973
0.8758 High Similarity NPC476459
0.8758 High Similarity NPC471114
0.8758 High Similarity NPC50394
0.8758 High Similarity NPC86477
0.8758 High Similarity NPC241820
0.875 High Similarity NPC304443
0.875 High Similarity NPC29411
0.875 High Similarity NPC74539
0.875 High Similarity NPC37183
0.875 High Similarity NPC474591
0.8742 High Similarity NPC71210
0.8742 High Similarity NPC311741
0.8742 High Similarity NPC272722
0.8742 High Similarity NPC234629
0.8742 High Similarity NPC271288
0.8734 High Similarity NPC49009
0.8733 High Similarity NPC73028

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC67654 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9034 High Similarity NPD2344 Approved
0.8792 High Similarity NPD2309 Approved
0.875 High Similarity NPD920 Approved
0.8726 High Similarity NPD3749 Approved
0.8716 High Similarity NPD1549 Phase 2
0.8649 High Similarity NPD1550 Clinical (unspecified phase)
0.8649 High Similarity NPD1552 Clinical (unspecified phase)
0.8639 High Similarity NPD1510 Phase 2
0.8621 High Similarity NPD1240 Approved
0.8618 High Similarity NPD4378 Clinical (unspecified phase)
0.8618 High Similarity NPD642 Clinical (unspecified phase)
0.8533 High Similarity NPD2800 Approved
0.8503 High Similarity NPD1607 Approved
0.8487 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD2796 Approved
0.8428 Intermediate Similarity NPD3882 Suspended
0.8377 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8365 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD1934 Approved
0.8344 Intermediate Similarity NPD3926 Phase 2
0.8333 Intermediate Similarity NPD1551 Phase 2
0.8323 Intermediate Similarity NPD6559 Discontinued
0.8302 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8291 Intermediate Similarity NPD7411 Suspended
0.8289 Intermediate Similarity NPD1243 Approved
0.8278 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD4380 Phase 2
0.8221 Intermediate Similarity NPD1247 Approved
0.8199 Intermediate Similarity NPD7768 Phase 2
0.8194 Intermediate Similarity NPD1511 Approved
0.8194 Intermediate Similarity NPD6799 Approved
0.8187 Intermediate Similarity NPD2801 Approved
0.8187 Intermediate Similarity NPD7819 Suspended
0.8182 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD7075 Discontinued
0.8137 Intermediate Similarity NPD2296 Approved
0.8117 Intermediate Similarity NPD3750 Approved
0.8113 Intermediate Similarity NPD6599 Discontinued
0.811 Intermediate Similarity NPD6959 Discontinued
0.8098 Intermediate Similarity NPD919 Approved
0.8089 Intermediate Similarity NPD1512 Approved
0.8084 Intermediate Similarity NPD3818 Discontinued
0.8075 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD5494 Approved
0.8025 Intermediate Similarity NPD2532 Approved
0.8025 Intermediate Similarity NPD2534 Approved
0.8025 Intermediate Similarity NPD2533 Approved
0.8 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD6166 Phase 2
0.7964 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD6232 Discontinued
0.7935 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD7473 Discontinued
0.7901 Intermediate Similarity NPD6280 Approved
0.7901 Intermediate Similarity NPD6801 Discontinued
0.7901 Intermediate Similarity NPD6279 Approved
0.7867 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7836 Intermediate Similarity NPD5953 Discontinued
0.7806 Intermediate Similarity NPD1471 Phase 3
0.7805 Intermediate Similarity NPD3817 Phase 2
0.7792 Intermediate Similarity NPD2799 Discontinued
0.7792 Intermediate Similarity NPD3748 Approved
0.7765 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD2935 Discontinued
0.7738 Intermediate Similarity NPD6808 Phase 2
0.7719 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7286 Phase 2
0.7716 Intermediate Similarity NPD3226 Approved
0.7684 Intermediate Similarity NPD4287 Approved
0.7677 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7074 Phase 3
0.7662 Intermediate Similarity NPD6651 Approved
0.7658 Intermediate Similarity NPD4628 Phase 3
0.7651 Intermediate Similarity NPD1203 Approved
0.7647 Intermediate Similarity NPD943 Approved
0.7632 Intermediate Similarity NPD2313 Discontinued
0.7616 Intermediate Similarity NPD5844 Phase 1
0.7616 Intermediate Similarity NPD4908 Phase 1
0.7616 Intermediate Similarity NPD7054 Approved
0.7593 Intermediate Similarity NPD5403 Approved
0.759 Intermediate Similarity NPD5402 Approved
0.7578 Intermediate Similarity NPD5401 Approved
0.7572 Intermediate Similarity NPD7472 Approved
0.7571 Intermediate Similarity NPD8434 Phase 2
0.753 Intermediate Similarity NPD1465 Phase 2
0.753 Intermediate Similarity NPD5761 Phase 2
0.753 Intermediate Similarity NPD5760 Phase 2
0.7529 Intermediate Similarity NPD6797 Phase 2
0.7516 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD3764 Approved
0.75 Intermediate Similarity NPD6832 Phase 2
0.75 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD7251 Discontinued
0.7468 Intermediate Similarity NPD2346 Discontinued
0.745 Intermediate Similarity NPD9717 Approved
0.7443 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD7808 Phase 3
0.7429 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD5711 Approved
0.7427 Intermediate Similarity NPD5710 Approved
0.7427 Intermediate Similarity NPD7229 Phase 3
0.7407 Intermediate Similarity NPD7390 Discontinued
0.7405 Intermediate Similarity NPD6099 Approved
0.7405 Intermediate Similarity NPD6100 Approved
0.7378 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD2654 Approved
0.7372 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD230 Phase 1
0.7371 Intermediate Similarity NPD1729 Discontinued
0.7368 Intermediate Similarity NPD2798 Approved
0.7362 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD3751 Discontinued
0.7351 Intermediate Similarity NPD1876 Approved
0.7347 Intermediate Similarity NPD1548 Phase 1
0.7342 Intermediate Similarity NPD7033 Discontinued
0.7333 Intermediate Similarity NPD3972 Approved
0.729 Intermediate Similarity NPD3268 Approved
0.7283 Intermediate Similarity NPD4361 Phase 2
0.7283 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD422 Phase 1
0.7261 Intermediate Similarity NPD447 Suspended
0.7241 Intermediate Similarity NPD2403 Approved
0.7241 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD4308 Phase 3
0.723 Intermediate Similarity NPD9545 Approved
0.7228 Intermediate Similarity NPD4363 Phase 3
0.7228 Intermediate Similarity NPD4360 Phase 2
0.7222 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD1608 Approved
0.7213 Intermediate Similarity NPD3269 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD2797 Approved
0.719 Intermediate Similarity NPD1470 Approved
0.7176 Intermediate Similarity NPD4288 Approved
0.7168 Intermediate Similarity NPD7199 Phase 2
0.7151 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1019 Discontinued
0.7123 Intermediate Similarity NPD1241 Discontinued
0.712 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD9494 Approved
0.7095 Intermediate Similarity NPD9493 Approved
0.7091 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1613 Approved
0.7086 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD3266 Approved
0.7078 Intermediate Similarity NPD3267 Approved
0.7078 Intermediate Similarity NPD1164 Approved
0.707 Intermediate Similarity NPD411 Approved
0.7059 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1933 Approved
0.7044 Intermediate Similarity NPD6355 Discontinued
0.7037 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD3787 Discontinued
0.702 Intermediate Similarity NPD17 Approved
0.7017 Intermediate Similarity NPD8313 Approved
0.7017 Intermediate Similarity NPD8312 Approved
0.7013 Intermediate Similarity NPD3225 Approved
0.7012 Intermediate Similarity NPD7003 Approved
0.7011 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4625 Phase 3
0.7 Intermediate Similarity NPD6104 Discontinued
0.6987 Remote Similarity NPD2861 Phase 2
0.6987 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6982 Remote Similarity NPD7458 Discontinued
0.6981 Remote Similarity NPD4307 Phase 2
0.6977 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6975 Remote Similarity NPD5408 Approved
0.6975 Remote Similarity NPD5404 Approved
0.6975 Remote Similarity NPD5406 Approved
0.6975 Remote Similarity NPD5405 Approved
0.6962 Remote Similarity NPD1296 Phase 2
0.6962 Remote Similarity NPD6798 Discontinued
0.6959 Remote Similarity NPD6844 Discontinued
0.6959 Remote Similarity NPD37 Approved
0.6954 Remote Similarity NPD6234 Discontinued
0.6946 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6936 Remote Similarity NPD4967 Phase 2
0.6936 Remote Similarity NPD4966 Approved
0.6936 Remote Similarity NPD4965 Approved
0.6933 Remote Similarity NPD6004 Phase 3
0.6933 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6933 Remote Similarity NPD6002 Phase 3
0.6933 Remote Similarity NPD6005 Phase 3
0.6933 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6932 Remote Similarity NPD5668 Clinical (unspecified phase)
0.6928 Remote Similarity NPD1201 Approved
0.6923 Remote Similarity NPD8151 Discontinued
0.6899 Remote Similarity NPD3027 Phase 3
0.6897 Remote Similarity NPD6971 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data